Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Elections for first interim dividend

20 Dec 2024 09:00

RNS Number : 8642Q
Experian plc
20 December 2024
Β 

Experian plc

Β 

Β 

Elections for first interim dividend in respect of the year ending 31 March 2025

Β 

Β 

20 December 2024 - Experian plc, the global data and technology company, hereby notifies the market that, following the announcement on 13 November 2024 of a first interim dividend of 19.25 US cents per ordinary share, payable on 7 February 2025 to shareholders on the register of members at the close of business on 10 January 2025, shareholders are reminded that the final date for submission of:

Β 

(a) elections to receive UK sourced dividends via the Income Access Share arrangements, and

Β 

(b) elections to receive dividends in US dollars

Β 

is 10 January 2025.

Β 

In the absence of any such elections, previous elections or deemed elections will remain in force.

Β 

Shareholders who do not elect (or have not been deemed to elect) to receive UK sourced dividends through the Income Access Share arrangements are reminded that their dividends will be Irish sourced and subject to Irish dividend withholding tax unless the Company's share registrars are in possession of a valid exemption form by 10 January 2025. Exemption forms should be delivered to the registrars' Dividend Planning Team so as to arrive no later than 5.30pm on 10 January 2025.

Β 

In addition, unless shareholders elect by 10 January 2025 to receive US dollars, their dividends will be paid in sterling at a rate per share calculated on the basis of the exchange rate from US dollars to sterling pounds on 17 January 2025. If you hold your shares in uncertificated form, that is via CREST, and wish to make an election to receive US dollars, your instruction should be made via the established procedure for dividend elections in CREST. Certificated holders who wish to make an election to receive US dollars should complete and lodge the election form which is available from the shareholder portal at experianplc.com/shares or by contacting the share registrars directly. All valid elections must be received by 10 January 2025.

Β 

Enquiries may be addressed to the share registrars' Dividend Planning Team on 0371 664 9245. Calls are charged at the standard geographic rate and will vary by provider. Calls made outside the United Kingdom will be charged at the applicable international rate. Lines are open from 8.30am to 5.30pm, Monday to Friday excluding public holidays in England and Wales. The address for the return of election forms is Link Market Services (Jersey) Limited, 12 Castle Street, St Helier, Jersey, JE2 3RT, Channel Islands.

Β 

Contact:

Β 

Experian

Charles Brown

Company Secretary

+353 (0) 86 819 4473

Β 

Β 

Β 

Β 

Β 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

Β 

We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland.

Β 

Learn more at experianplc.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DIVPPGGGPUPCUGU
Date   Source Headline
7th Feb 20249:14 amRNSAdditional Listing
6th Feb 20243:47 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
31st Jan 20249:20 amRNSAdditional Listing
24th Jan 20249:47 amRNSAdditional Listing
17th Jan 202412:44 pmRNSDirector/PDMR Shareholding
17th Jan 20249:44 amRNSAdditional Listing
16th Jan 20247:00 amRNSExperian Q3 FY24 trading update
12th Jan 20245:44 pmRNSFirst Interim Dividend
10th Jan 202410:55 amRNSAdditional Listing
3rd Jan 20249:02 amRNSAdditional Listing
29th Dec 202310:03 amRNSTotal Voting Rights
15th Dec 20239:32 amRNSElections for first interim dividend
13th Dec 20239:31 amRNSAdditional Listing
6th Dec 20239:14 amRNSAdditional Listing
30th Nov 202312:14 pmRNSTotal Voting Rights
29th Nov 20239:43 amRNSAdditional Listing
22nd Nov 20239:25 amRNSAdditional Listing
15th Nov 20237:00 amRNSHalf-year Report
10th Nov 20239:00 amRNSDirector Declaration
31st Oct 20235:04 pmRNSTransaction in Own Shares
31st Oct 202312:22 pmRNSTotal Voting Rights
30th Oct 20235:13 pmRNSTransaction in Own Shares
27th Oct 20235:32 pmRNSTransaction in Own Shares
26th Oct 20235:44 pmRNSTransaction in Own Shares
25th Oct 20235:17 pmRNSTransaction in Own Shares
24th Oct 20235:42 pmRNSTransaction in Own Shares
11th Oct 20239:46 amRNSAdditional Listing
6th Oct 20233:30 pmRNSShare repurchase programme
4th Oct 20239:04 amRNSAdditional Listing
27th Sep 20235:07 pmRNSTransaction in Own Shares
27th Sep 20239:50 amRNSAdditional Listing
26th Sep 20235:08 pmRNSTransaction in Own Shares
25th Sep 20235:47 pmRNSTransaction in Own Shares
20th Sep 20239:13 amRNSAdditional Listing
19th Sep 20232:45 pmRNSBlock listing Interim Review
13th Sep 20239:30 amRNSAdditional Listing
31st Aug 202312:32 pmRNSTotal Voting Rights
30th Aug 20239:25 amRNSAdditional Listing
23rd Aug 20235:34 pmRNSTransaction in Own Shares
23rd Aug 20239:32 amRNSAdditional Listing
22nd Aug 20235:54 pmRNSTransaction in Own Shares
16th Aug 20239:16 amRNSAdditional Listing
9th Aug 20239:30 amRNSAdditional Listing
2nd Aug 20239:16 amRNSAdditional Listing
31st Jul 202312:05 pmRNSTotal Voting Rights
26th Jul 202310:00 amRNSAdditional Listing
25th Jul 20232:30 pmRNSDirector/PDMR Shareholding
25th Jul 202310:30 amRNSDirector/PDMR Shareholding
19th Jul 20232:32 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.